JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$883M |
| 2 |
Walt Disney
DIS
|
+$735M |
| 3 |
Nike
NKE
|
+$722M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$648M |
| 5 |
Philip Morris
PM
|
+$632M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.21B |
| 2 |
Meta Platforms (Facebook)
META
|
+$689M |
| 3 |
Broadcom
AVGO
|
+$633M |
| 4 |
Gilead Sciences
GILD
|
+$608M |
| 5 |
MetLife
MET
|
+$587M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.21% |
| 2 | Technology | 10.97% |
| 3 | Healthcare | 8.87% |
| 4 | Consumer Discretionary | 8.27% |
| 5 | Industrials | 7.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
USG
826
DELISTED
Usg
USG
| $63.2M | 0.01% |
1,986,738
+1,798,074
| +953% | +$57.2M |
|
827
Royal Bank of Canada
RY
$293B
| $63.1M | 0.01% |
866,008
-113,986
| -12% | -$8.26M |
|
828
Aramark
ARMK
$14.7B
| $63.1M | 0.01% |
2,371,368
-420,483
| -15% | -$10.7M |
|
829
ICU Medical
ICUI
$4.61B
| $63M | 0.01% |
412,388
-26,921
| -6% | -$3.93M |
|
830
CALL
Microsoft
MSFT
$3.71T
| $62.5M | 0.01% |
948,400
+415,000
| +78% | +$26.6M |
|
|
MGLN
831
DELISTED
Magellan Health Services, Inc.
MGLN
| $61.7M | 0.01% |
893,272
+43,827
| +5% | +$3.2M |
|
832
Acadia Pharmaceuticals
ACAD
$5.03B
| $61.4M | 0.01% |
1,786,424
-273,408
| -13% | -$9.65M |
|
833
Cabot Corp
CBT
$4.52B
| $61.4M | 0.01% |
1,025,118
-119,076
| -10% | -$6.77M |
|
834
SBA Communications
SBAC
$19.5B
| $61.4M | 0.01% |
509,845
+83,087
| +19% | +$9.18M |
|
835
Commerce Bancshares
CBSH
$8.5B
| $61.3M | 0.01% |
1,694,358
+181,092
| +12% | +$6.68M |
|
836
Acushnet Holdings
GOLF
$5.45B
| $61.3M | 0.01% |
3,548,698
+1,001,850
| +39% | +$18.2M |
|
|
RDS.A
837
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
| $60.9M | 0.01% |
1,175,119
-276,375
| -19% | -$14.4M |
|
|
INVX
838
Innovex International
INVX
$1.97B
| $60.2M | 0.01% |
1,103,475
+103,634
| +10% | +$6.19M |
|
|
CHMT
839
DELISTED
Chemtura Corporation
CHMT
| $60.1M | 0.01% |
1,798,940
-24,629
| -1% | -$817K |
|
|
WGL
840
DELISTED
Wgl Holdings
WGL
| $59.6M | 0.01% |
722,496
+558,565
| +341% | +$45.5M |
|
841
Moelis & Co
MC
$4.94B
| $59.5M | 0.01% |
1,546,458
+292,662
| +23% | +$10.6M |
|
|
HOLX
842
DELISTED
Hologic
HOLX
| $59.5M | 0.01% |
1,398,863
-302,030
| -18% | -$12.3M |
|
|
SEP
843
DELISTED
Spectra Engy Parters Lp
SEP
| $59.5M | 0.01% |
1,362,123
+82,418
| +6% | +$3.68M |
|
|
IPHI
844
DELISTED
INPHI CORPORATION
IPHI
| $59.4M | 0.01% |
1,217,751
-99,885
| -8% | -$4.66M |
|
845
Popular Inc
BPOP
$11.1B
| $59.4M | 0.01% |
1,459,329
+66,211
| +5% | +$2.86M |
|
|
846
PUT
Meta Platforms (Facebook)
META
$1.51T
| $59.4M | 0.01% |
417,930
+229,850
| +122% | +$30.7M |
|
|
SAGE
847
DELISTED
Sage Therapeutics
SAGE
| $59.3M | 0.01% |
834,295
-164,492
| -16% | -$9.64M |
|
848
CALL
ExxonMobil
XOM
$634B
| $59.2M | 0.01% |
721,391
-338,757
| -32% | -$28.3M |
|
849
Intuit
INTU
$89B
| $59.1M | 0.01% |
509,617
+359,773
| +240% | +$43.1M |
|
850
Molina Healthcare
MOH
$10.3B
| $59M | 0.01% |
1,294,516
+504,014
| +64% | +$26.4M |
|
Similar funds
JP Morgan Chase's Q1 2017 Portfolio in Review
As of Q1 2017, JP Morgan Chase held 5,473 positions worth $438B, up 5.1% from $416B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
JP Morgan Chase's Q1 2017 filing shows 430 new, 1,777 increased, 2,381 reduced and 409 closed positions. Its largest new stake was Snap: 11,202,277 shares worth $252M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $2.21B.
By sector, the portfolio is most concentrated in Financials at 14% of assets, down from 15% a quarter earlier, followed by Technology and Healthcare.
- JP Morgan Chase's largest Q1 2017 buy was Snap: 11,202,277 shares worth $252M.
- JP Morgan Chase added most to Apple in Q1 2017, an estimated $883M increase.
- JP Morgan Chase's biggest Q1 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $2.21B.
- JP Morgan Chase fully exited Linear Technology Corp in Q1 2017, selling an estimated $282M.
- JP Morgan Chase's ten largest holdings make up 17% of its $438B portfolio in Q1 2017.
- JP Morgan Chase opened 430 new positions and closed 409 in Q1 2017.
- JP Morgan Chase's portfolio value rose 5.1% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q1 2017, filed 10 May 2017.